1. Almousa, Hashem, Lewis, Sara A, Bakhtiari, Somayeh, Sacher, Michael, Kruer, Michael C. . TRAPPC6B biallelic variants cause a neurodevelopmental disorder with TRAPP II and trafficking disruptions. In Brain : a journal of neurology, 147, 311-324. doi:10.1093/brain/awad301. https://pubmed.ncbi.nlm.nih.gov/37713627/
2. Aridon, Paolo, De Fusco, Maurizio, Winkelmann, Juliane W, Ferini-Strambi, Luigi, Casari, Giorgio. 2016. A TRAPPC6B splicing variant associates to restless legs syndrome. In Parkinsonism & related disorders, 31, 135-138. doi:10.1016/j.parkreldis.2016.08.016. https://pubmed.ncbi.nlm.nih.gov/27569842/
3. Luo, Hou-Long, Pi, Jiang, Zhang, Jun-Ai, Chen, Zheng W, Xu, Jun-Fa. 2021. Circular RNA TRAPPC6B inhibits intracellular Mycobacterium tuberculosis growth while inducing autophagy in macrophages by targeting microRNA-874-3p. In Clinical & translational immunology, 10, e1254. doi:10.1002/cti2.1254. https://pubmed.ncbi.nlm.nih.gov/33708385/
4. Kouzel, Ivan U, Kehl, Alexander, Berger, Petya, Mellmann, Alexander, Müthing, Johannes. 2020. RAB5A and TRAPPC6B are novel targets for Shiga toxin 2a inactivation in kidney epithelial cells. In Scientific reports, 10, 4945. doi:10.1038/s41598-020-59694-w. https://pubmed.ncbi.nlm.nih.gov/32188865/